Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 06, 2020

SELL
$9.57 - $21.32 $494,807 - $1.1 Million
-51,704 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$12.21 - $16.99 $501,745 - $698,170
41,093 Added 387.27%
51,704 $761,000
Q1 2020

May 08, 2020

BUY
$9.03 - $19.72 $47,163 - $102,997
5,223 Added 96.94%
10,611 $142,000
Q4 2019

Feb 04, 2020

BUY
$13.01 - $17.15 $70,097 - $92,404
5,388 New
5,388 $76,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.